Blog

White Collar Law & Investigations

Keeping you aprised of the developing regulatory environment that confronts businesses and individuals in virtually any industry. Whether federal or state investigations, enforcement actions, changing enforcement priorities, criminal prosecutions or related civil proceedings, we provide regular coverage and updates that draw on the deep experience.

1099 vs. W-2 Medical Device Sales Reps: Why Langer v. Zimmer Biomet Is Not a Green Light for Independent Contractor Commissions Under the Anti-Kickback Statute
Blog October 29, 2026
A Massachusetts federal court rejects a per se rule against commission-based independent contractor reps -- but the ruling may prove an outlier, and it is not a green light for 1099 commissions…
Drawing the Line on Product Support: District of Massachusetts Rejects AKS Claims Against Manufacturer’s Infusible Biologics Support Program
Blog October 13, 2026
On September 30, 2026, the District of Massachusetts granted summary judgment to Janssen Biotech and denied the relator’s cross-motion, finding insufficient evidence of either unlawful remuneration or knowing and willful conduct under the AKS…
2026 Health Care Fraud Year in Preview
Blog January 16, 2026
This is the first in our 2026 Year in Preview series examining important trends in white collar law and investigations in the coming year. Up next: Anti-corruption/ FCPA Enforcement…
Federal District Court Upholds HHS Advisory Opinion Blocking Fertility Assistance Program
Blog May 01, 2025
A recent decision from the United States District Court for the District of Columbia continues to give significant deference to the U.S. Department of Health and Human Services’ (HHS) interpretation of the Anti-Kickback and Beneficiary Inducement Statutes, particularly where it involves the evaluation of scientific data within the technical expertise of the HHS and where the HHS’s assessment is predictive…
False Claims Act in 2025: Looking Back and What’s Ahead
Blog February 28, 2025
The Attorney General and key Department of Justice leadership are now in place and appear to have hit the ground running…
New Massachusetts Healthcare Law Targets Private Equity, REITs, and MSOs; Expands State False Claims Act
Blog February 05, 2025
On January 8, 2025, Governor Maura Healey signed House Bill 5159 into law, toughening the rules and increasing the risks for private equity (PE) companies, real estate investment trusts (REITs), and management services organizations (MSOs) doing business with Massachusetts healthcare providers…
Health Care Fraud Enforcement in 2025
Blog January 10, 2025
We kick off our annual Year in Preview series with a comprehensive look at health care fraud enforcement in 2025…
Hospital Avoids Admissions in False Claims Act Settlement, While Repeat Relator and Government Cash in on Medical Necessity Allegations
Blog December 13, 2024
There was a noteworthy False Claims Act (FCA) settlement made public yesterday out of the Eastern District of California involving Oroville Hospital. The government accused the Hospital of submitting false claims to Medicare and Medicaid (Medi-Cal), including claims relying on false diagnosis codes…
1 of 4

ABOUT

The Foley Hoag White Collar Law & Investigations blog addresses the developing regulatory environment that confronts businesses and individuals in virtually any industry.  Whether federal or state investigations, enforcement actions, changing enforcement priorities, criminal prosecutions or related civil proceedings, the White Collar Law & Investigations blog will provide regular coverage and updates that draw on the deep experience of Foley Hoag’s White Collar Crime & Government Investigations practice.

Our attorneys have represented companies and executives in criminal, regulatory, and civil investigations involving a wide range of governmental authorities – the U.S. Department of Justice, U.S. Attorney’s Offices, the U.S. Securities and Exchange Commission, Congressional oversight committees, state Attorneys General, and numerous federal and state departments and agencies. Our clients include global, national and regional companies in many industries: technology; pharmaceuticals and medical devices; health care; financial services; securities; insurance; environmental technology; manufacturing; and government.

The White Collar Law & Investigations blog will reflect the breadth of this experience and knowledge. Please contact us to share your thoughts on the blog or if we can assist you in navigating today’s complex regulatory environment.